We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$354B
| $69.7M | 0.49% |
1,559,419
+225,972
| +17% | +$10.4M |
|
27
Salesforce
CRM
$134B
| $68.6M | 0.49% |
366,452
-130,698
| -26% | -$22M |
|
28
Mastercard
MA
$477B
| $68.6M | 0.48% |
232,008
-82,030
| -26% | -$23.1M |
|
29
Applied Materials
AMAT
$426B
| $66.6M | 0.47% |
1,101,189
+113,212
| +11% | +$6.11M |
|
|
SWT
30
DELISTED
Stanley Black & Decker, Inc.
SWT
| $63.1M | 0.45% |
705,710
+171,303
| +32% | +$13.9M |
|
|
SRE.PRA
31
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $63.1M | 0.45% |
646,054
-441
| -0.1% | -$45.1K |
|
32
Walmart Inc
WMT
$871B
| $62.2M | 0.44% |
1,557,402
+132,207
| +9% | +$5.44M |
|
33
Nike
NKE
$61.9B
| $60.7M | 0.43% |
618,963
-91,691
| -13% | -$8.46M |
|
|
BSX.PRA
34
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $59.7M | 0.42% |
+569,916
| New | +$61M |
|
|
DHR.PRA
35
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $59.5M | 0.42% |
47,704
+3,453
| +8% | +$4.07M |
|
36
AT&T
T
$165B
| $58.8M | 0.42% |
2,573,395
+87,572
| +4% | +$1.99M |
|
37
Cisco
CSCO
$450B
| $57.9M | 0.41% |
1,241,931
-57,064
| -4% | -$2.5M |
|
38
PayPal
PYPL
$49.5B
| $57.7M | 0.41% |
331,371
-1,943
| -0.6% | -$269K |
|
39
Eli Lilly
LLY
$1.07T
| $56.1M | 0.4% |
341,850
+88,227
| +35% | +$13.5M |
|
|
AIZP
40
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
| $55.5M | 0.39% |
533,415
+32,159
| +6% | +$3.38M |
|
41
Berkshire Hathaway Class B
BRK.B
$1.07T
| $53M | 0.38% |
297,175
-61,260
| -17% | -$11.2M |
|
42
Merck
MRK
$324B
| $53M | 0.37% |
718,330
-99,893
| -12% | -$7.52M |
|
43
CSX Corp
CSX
$98.6B
| $50.9M | 0.36% |
2,190,876
+368,730
| +20% | +$8.16M |
|
|
44
RTX Corp
RTX
$287B
| $50.4M | 0.36% |
817,539
+612,933
| +300% | +$38.2M |
|
|
45
Vertex Pharmaceuticals
VRTX
$121B
| $49.9M | 0.35% |
171,944
+57,288
| +50% | +$15.5M |
|
46
McDonald's
MCD
$188B
| $49.9M | 0.35% |
270,370
-29,479
| -10% | -$5.41M |
|
47
Netflix
NFLX
$292B
| $49.7M | 0.35% |
1,091,860
-131,570
| -11% | -$5.6M |
|
48
Intel
INTC
$466B
| $49.5M | 0.35% |
827,763
-42,388
| -5% | -$2.53M |
|
|
AEPPL
49
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $49.4M | 0.35% |
1,020,708
-942
| -0.1% | -$47.3K |
|
50
Bank of America Series L
BAC.PRL
$3.95B
| $49.3M | 0.35% |
36,733
+3,587
| +11% | +$4.85M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.